Sci­ence 37, one of the star­tups that fu­eled the rise in de­cen­tral­ized clin­i­cal tri­als, will go pri­vate and see its one-time $1 bil­lion val­u­a­tion evap­o­rate … ...

HHS on Fri­day an­nounced its se­lec­tions for the next-gen­er­a­tion of Covid-19 vac­cine can­di­dates to re­ceive $500 mil­lion in fund­ing as part of the gov­ern­ment’s Project … ...

The Fed­er­al Trade Com­mis­sion wants more in­for­ma­tion on Pfiz­er’s takeover of Seagen be­fore it will make a rul­ing on whether it will clear the … ...

Just a few days af­ter pric­ing a $150 mil­lion pub­lic of­fer­ing, Io­vance has now closed with 15% more raised, thanks to … ...

A bill that re­quires the Di­rec­tor of Na­tion­al In­tel­li­gence to de­clas­si­fy new in­for­ma­tion on the ori­gins of Covid-19 passed the House … ...

When Pres­i­dent Joe Biden’s bud­get comes out on Thurs­day, ex­pect to see a big, po­ten­tial­ly mul­ti-bil­lion-dol­lar pro­pos­al to re­al­ly take a crack at cur­ing more … ...

Fol­low­ing opi­oid-re­lat­ed set­tle­ments from CVS and Wal­greens with states and oth­er na­tion­al groups, Wal­mart is now do­ing the same: not ad­mit­ting any guilt but agree­ing … ...

As part of an at­tempt to halt a like­ly new surge of hos­pi­tal­iza­tions and deaths from Omi­cron’s BA.5 sub­vari­ant this fall, the FDA on Wednes­day … ...

The Jacque­line Shea era at In­ovio will start with a sweep­ing re­or­ga­ni­za­tion.

Il­lu­mi­na Ven­tures closed off its sec­ond in­vest­ment fund with a to­tal com­mit­ment of $325 mil­lion, of­fer­ing fresh fu­el to back a … ...

Alex Gorsky, the CEO whose nine-year tenure at J&J was marred by law­suits over the com­pa­ny’s talc ba­by pow­der and opi­oids, will ...

A whole in­dus­try may have been born out of the spec­tac­u­lar suc­cess of CD19 CAR-T, push­ing the en­ve­lope on next-gen­er­a­tion con­structs hit­ting new tar­gets. But … ...